Kirsten graduated from Aston University (Birmingham, UK) in 2002 obtaining a First Class Master’s degree in Pharmacy (MPharm). He undertook an internship split between the Royal United Hospital (Bath, UK) and Sainsbury’s Pharmacy Group in Bath where upon registration with the Royal Pharmaceutical Society he became Pharmacy Manager. In 2006 Kirsten commenced a PhD at Kings College London in collaboration with MedPharm Ltd (Guildford, UK) and Transport Pharma (Boston, US). The PhD project investigated the active transport of small ionic complexes across the skin using iontophoresis to enhance wound healing.
Upon completing his PhD Kirsten undertook a role at the University of Hertfordshire (UK) as a Lecturer in... Read more
About me
Kirsten graduated from Aston University (Birmingham, UK) in 2002 obtaining a First Class Master’s degree in Pharmacy (MPharm). He undertook an internship split between the Royal United Hospital (Bath, UK) and Sainsbury’s Pharmacy Group in Bath where upon registration with the Royal Pharmaceutical Society he became Pharmacy Manager. In 2006 Kirsten commenced a PhD at Kings College London in collaboration with MedPharm Ltd (Guildford, UK) and Transport Pharma (Boston, US). The PhD project investigated the active transport of small ionic complexes across the skin using iontophoresis to enhance wound healing.
Upon completing his PhD Kirsten undertook a role at the University of Hertfordshire (UK) as a Lecturer in Pharmaceutics during which he completed his diploma in Higher Education. Here he coordinated diverse undergraduate courses within the pharmacy program including Medicines and Pharmacy Practice, Pharmaceutical and Medical Microbiology and Pharmacy Business Management.
Kirsten moved to Adelaide during 2010 to undertake a position as Lecturer in Clinical Pharmacy at UniSA where he is the director of the professionally accredited pharmacy undergraduate program. Kirsten currently coordinates Pharmacy Practice 1 and Advanced Therapeutics and continues to teach dermatology across the program. Current projects include biosimilar medicine literature reviews on behalf of the Department of Health biosimilar awareness initiative and now for GBMA Education under the Biosimilar Education Grant.
About me
Australasian Pharmaceutical Science Association Council Member (Education)
Pharmaceutical Society of Australia
Australian Pharmaceutical Formulary
Fellow of the Higher Education Academy
Australian Pharmacy Council
Royal Pharmaceutical Society of Great Britain
About me
Doctor of Philosophy in Pharmacy Kings College London
Master of Pharmacy Aston University
Postgrad Cert In Learning and Teaching in Higher Education University of Hertfordshire
Royal United Hospital Bath UK (2003-2004)
Sainsburys Pharmacy Ltd UK (2004 - 2010)
King's College London UK (2006 - 2008)
University of Hertfordshire UK (2008 - 2010)
University of South Australia (2010 - Present)
Biosimilar Awareness Initiative -
Biological and biosimilar medicines are used to treat serious diseases such as cancers, diabetes, inflammatory digestive disorders and arthritis. Biosimilar medicines have been used for over 10 years. They are now used in over 60 countries. Lower costs and increased access to medicines has been demonstrated internationally. This shows promise for Australia. The Awareness Initiative was announced in May 2015 as part of the Pharmaceutical Benefits Scheme Access and Sustainability Package. The aim of the Initiative is to support awareness of, and confidence in, the use of biosimilar medicines for healthcare professionals and consumers. Our group has been commissioned by the Department of Health to provide... Read more
Research
Excludes commercial-in-confidence projects.
Literature Review of International Biosimilar Medicines, Cwth Dept of Health, 01/03/2016 - 30/06/2018
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2017 |
3
3
6
|
2014 |
|
2010 |
9
7
|
Year | Output |
---|---|
2021 |
Open access
|
2020 |
Open access
|
2020 |
Open access
|
2020 |
Open access
|
2020 |
Open access
|
2019 |
Open access
|
2019 |
Open access
|
2019 |
Open access
|
2019 |
Open access
|
2018 |
Open access
|
2018 |
Open access
|
2018 |
Open access
|
2017 |
Open access
|
2017 |
Open access
|
2017 |
Open access
|
2017 |
Open access
|
2016 |
Open access
|
2016 |
Open access
|
2016 |
Open access
|
Research
Biosimilar Awareness Initiative -
Biological and biosimilar medicines are used to treat serious diseases such as cancers, diabetes, inflammatory digestive disorders and arthritis. Biosimilar medicines have been used for over 10 years. They are now used in over 60 countries. Lower costs and increased access to medicines has been demonstrated internationally. This shows promise for Australia. The Awareness Initiative was announced in May 2015 as part of the Pharmaceutical Benefits Scheme Access and Sustainability Package. The aim of the Initiative is to support awareness of, and confidence in, the use of biosimilar medicines for healthcare professionals and consumers. Our group has been commissioned by the Department of Health to provide the independent literature review as part of this initiative, including ongoing quarterly updates. This work is ongoing on behalf of the Department of Health biosimilar awareness initiative and now for GBMA Education under the Biosimilar Education Grant.
Dermal/Transdermal drug delivery -
The delivery of drugs via the skin is the second most successful route for drug administration due to the potential for avoiding the problems commonly associated with oral delivery such as first pass metabolism and systemic toxicity. My research in this field has focused on the development of novel formulations to enhance drug deposition within the skin using both passive and active mechanisms.
Palliative Care -
In Australia, a home death is a reality for only a small proportion of terminal patients, despite evidence that most indicate the family home as their preference. A critical enabler for people to remain at home is good symptom control. However, access to medicines through community pharmacies has been problematic, with pharmacists unable to anticipate which injectable medicines to stock. Consequently, a multidisciplinary group of South Australian palliative care practitioners have developed a “core medicines list” to increase the likelihood that these medicines will be available. Our reaserch aims to identify and describe the key considerations for the implementation of the core medicines list to improve access to medicines for people who wish to remain in the community during the terminal phase.
Education -
Multiple definitions of interprofessional education have been put forward but there is a growing consensus that it designates joint learning by practitioners or students of more than one profession to enhance collaborative practice. There is, however, a great deal of diversity in how this is incorporated in health programmes across Australia and evidence of its effectiveness and perception amongst students is well acknowledged to be lacking across the sector. A unique opportunity for midwifery and pharmacy students to collaborate in a simulated clinical setting is being investigated. The introduction of increased IPL within the programmes at UniSA is encouraged however the evidence base of their effectiveness and value amongst students is largely unsubstantiated. As this will be the first project undertaken jointly between pharmacy and midwifery in Australia the findings will be novel and will be generalizable across multiple programmes. This pilot research study will begin to address these issues as we look to build upon the connections between different programmes within the university.
External engagement & recognition
Organisation | Country |
---|---|
Flinders University | AUSTRALIA |
Keele University | UNITED KINGDOM |
King's College London | UNITED KINGDOM |
Newcastle University, United Kingdom | UNITED KINGDOM |
University of Hertfordshire | UNITED KINGDOM |
University of South Australia | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
FellowHigher Education Academy, United Kingdom |
2018 |
Medical Science Reviewer, Bellberry Human Research Ethics CommitteeBellberry Limited |
2018 |
MemberPharmaceutical Society of Australia (PSA) |
2018 |
MemberRoyal Pharmaceutical Society of Great Britain |
2018 |
Member, Biosimilar Awareness initiative, National Medicines PolicyDepartment of Health, Australian Government |
2018 |
Member, Examination Editorial PanelAustralian Pharmacy Council |
2018 |
Program Committee, Council member (Education)Australasian Pharmaceutical Science Association (APSA) |
2018 |
ReviewerAustralian Pharmaceutical Formulary (APF) |
2018 |
FellowHigher Education Academy, United Kingdom |
2017 |
Medical Science Reviewer, Bellberry Human Research Ethics CommitteeBellberry Limited |
2017 |
MemberPharmaceutical Society of Australia (PSA) |
2017 |
MemberRoyal Pharmaceutical Society of Great Britain |
2017 |
Member, Biosimilar Awareness initiative, National Medicines PolicyDepartment of Health, Australian Government |
2017 |
Member, Examination Editorial PanelAustralian Pharmacy Council |
2017 |
Program Committee, Council member (Education)Australasian Pharmaceutical Science Association (APSA) |
2017 |
ReviewerAustralian Pharmaceutical Formulary (APF) |
2017 |
Medical Science Reviewer, Bellberry Human Research Ethics CommitteeBellberry Limited |
2016 |
MemberPharmaceutical Society of Australia (PSA) |
2016 |
Member, Biosimilar Awareness initiative, National Medicines PolicyDepartment of Health, Australian Government |
2016 |
Member, Examination Editorial PanelAustralian Pharmacy Council |
2016 |
Program Committee, Council member (Education)Australasian Pharmaceutical Science Association (APSA) |
2016 |
ReviewerAustralian Pharmaceutical Formulary (APF) |
2016 |
Medical Science Reviewer, Bellberry Human Research Ethics CommitteeBellberry Limited |
2015 |
MemberPharmaceutical Society of Australia (PSA) |
2015 |
Member, Examination Editorial PanelAustralian Pharmacy Council |
2015 |
Member, Examination Editorial PanelAustralian Pharmacy Council |
2014 |
As Program Director for pharmacy I am responsible for the quality of the undergraduate teaching across the pharmacy program. The program has been specifically designed to incorporate broad and diverse teaching modalities and provide effective scaffolding to encourage student development in a safe yet challenging environment. I am passionate about teaching all elements of physical, clinical and professional pharmacy. I belive in the value of connecting the key scientific principles which underpin the profession of pharmacy, namely pharmaceutics, pharmacology and therapeutics with delivery of high quality, evidence based, patient focussed clinical practice. As such I teach into a broad range of courses in the pharmacy undergraduate program including Health Professional Essentials, Pharmacology, Pharmacotherapeutics, Advanced Therapeutics, Quality Use of Medicines and Pharmacy Practice.
I have a particular interest in the impact of complex biologic medicines on the managment of chronic disease states.
Teaching & student supervision